BPC-157 Peptide Research Hub — Body Protection Compound Studies
BPC-157 is a stable pentadecapeptide fragment derived from human gastric juice protein. It is one of the most extensively cited compounds in tissue-repair and angiogenesis research, frequently studied alongside Thymosin Beta-4 (TB-500).
What this hub covers
- Stable pentadecapeptide sequence and gastric-juice origin
- Angiogenesis and VEGFR2 pathway literature
- Tendon, ligament and gut-mucosa research models
- Nitric oxide synthase pathway interactions
- Comparisons and synergy with TB-500 (Thymosin Beta-4)
BPC-157 research articles
All research →BPC-157 Half-Life & Pharmacokinetics — Research Guide (2026)
Research-only pharmacokinetic profile of BPC-157: serum half-life, Tmax, route comparisons, clearance and bioavailability — curated from published preclinical and clinical PK literature.
Read article →Thymosin Alpha-1 vs BPC-157 — Research Comparison (2026)
Thymosin Alpha-1 vs BPC-157: immune modulation vs tissue repair, mechanism, dosing and which to choose for a research endpoint.
Read article →What is BPC-157? A Research Primer
A comprehensive research primer on BPC-157 (Body Protection Compound-157) — a pentadecapeptide derived from human gastric juice. Covers origins, mechanism of action, tendon and gut healing research, angiogenesis, and CNS research findings.
Read article →BPC-157 Benefits and Side Effects: A Research Guide
A literature-grounded reference for BPC-157's reported mechanisms, benefits across preclinical tissue-repair models, and documented safety profile — for research use only.
Read article →BPC-157 vs TB-500: Tissue Repair Research Comparison
Compare BPC-157 and TB-500 (thymosin beta-4 fragment) — two leading tissue-repair research peptides — across mechanism, half-life, and published findings.
Read article →GHK-Cu vs BPC-157: Tissue & Skin Research Comparison
Compare GHK-Cu copper peptide and BPC-157 in skin, tissue repair, and regenerative research models.
Read article →BPC-157 Dosing & Protocols — Research Reference
Reference compilation of BPC-157 reconstitution, dose ranges, scheduling, cycling, and endpoint markers from the published research literature.
Read article →BPC-157 + TB-500 Stack Protocols — Research Reference
Reference compilation of BPC-157 + TB-500 combined tissue-repair research protocols, dosing, and endpoint pairing.
Read article →BPC-157 Reconstitution & Storage — Research Guide
Reference guide for BPC-157 reconstitution ratios, concentration tables, bacteriostatic water volumes, refrigerated stability, and lab-grade handling practice.
Read article →BPC-157 Safety Profile — Preclinical Research Reference
Preclinical safety record of stable gastric pentadecapeptide BPC-157: LD50 data, organ toxicity, acute and chronic exposure literature, and the absence of validated human safety studies.
Read article →BPC-157 Mechanism of Action — Angiogenesis, NO Pathway &
Proposed mechanisms of stable gastric pentadecapeptide BPC-157: VEGFR2 phosphorylation, nitric oxide pathway modulation, growth-factor crosstalk and gastrointestinal cytoprotection.
Read article →BPC-157 research FAQ
- What is BPC-157?
- BPC-157 (Body Protection Compound) is a 15-amino-acid peptide derived from a protective protein in human gastric juice. It is extensively studied in animal models of tendon, ligament, muscle and gastrointestinal tissue repair.
- How does BPC-157 differ from TB-500?
- BPC-157 acts primarily through VEGFR2-mediated angiogenesis and nitric oxide pathway modulation; TB-500 (Thymosin Beta-4) acts via actin sequestration and cell migration. They are often studied together for complementary repair mechanisms — see the BPC-157 vs TB-500 comparison.
- Is BPC-157 stable at room temperature?
- Lyophilized BPC-157 is unusually stable for a peptide and remains intact at room temperature for short periods, but for research use long-term storage at 2–8 °C protected from light is standard.
- What models is BPC-157 most cited in?
- Rodent models of Achilles tendon transection, muscle crush injury, gastric ulceration and inflammatory bowel disease — see the BPC-157 primer in the featured articles for citation-by-citation summaries.
All content on this hub is provided strictly for laboratory research purposes. Compounds listed are not for human or veterinary consumption. See our research-use disclosure for full terms.